<DOC>
	<DOCNO>NCT00457470</DOCNO>
	<brief_summary>This study evaluate safety efficacy AG-014699 diabetic patient</brief_summary>
	<brief_title>A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema ( DME )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Rucaparib</mesh_term>
	<criteria>diabetic patient , either man woman , diabetic retinopathy , least 18 year age patient treat laser therapy within last 90 day patient likelyhood require cataract surgery within 3 month Uncontrolled diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>